Cargando…

Report on Late Toxicity in Head-and-Neck Tumor Patients with Long Term Survival after Radiochemotherapy

SIMPLE SUMMARY: Regular tumor follow-up care provided by ear-nose-throat specialists ends when patients reach 5-year survival, but radio-toxicity is a lifelong process. In this study, long-term head-and-neck cancer survivors undergoing tumor FU-care exceeding five years were analyzed for late onset...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchberger, Anna Maria Stefanie, Strzelczyk, Elmar Anton, Wollenberg, Barbara, Combs, Stephanie Elisabeth, Pickhard, Anja, Pigorsch, Steffi Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428357/ https://www.ncbi.nlm.nih.gov/pubmed/34503101 http://dx.doi.org/10.3390/cancers13174292

Ejemplares similares

The role of psycho-oncologic screenings in the detection and evaluation of depression in head and neck cancer aftercare patients
por: Hadas, Stefan, et al.
Publicado: (2021)

Radiooncological View on Therapy Outcome after Multidisciplinary Treatment of Sinonasal Tumors
por: Klymenko, Olena, et al.
Publicado: (2021)

Reduced volume SIB-IMRT/IGRT to head and neck cancer in elderly and frail patients: outcome and toxicity
por: Straube, Christoph, et al.
Publicado: (2016)

Editorial: Challenges and their implications for the clinical practice of head and neck cancer
por: Wirth, Markus, et al.
Publicado: (2023)

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
por: De-Colle, Chiara, et al.
Publicado: (2017)

Correlation between delivered radiation doses to the brainstem or vestibular organ and nausea & vomiting toxicity in patients with head and neck cancers – an observational clinical trial
por: Schiller, Kilian, et al.
Publicado: (2017)

Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
por: Wolff, Hendrik Andreas, et al.
Publicado: (2008)

Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways
por: Pickhard, Anja C, et al.
Publicado: (2011)

Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation
por: Koch, Dominik Thomas, et al.
Publicado: (2017)

The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma
por: Baumann, Alexander, et al.
Publicado: (2018)

Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol
por: Pigorsch, Steffi U., et al.
Publicado: (2017)

Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer
por: Schäfer, C, et al.
Publicado: (2006)

Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2013)

Radiochemotherapy fosters a favorable pattern of inflammatory cells in head and neck tumors
por: Distel, Luitpold, et al.
Publicado: (2012)

Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy
por: Thureau, Sébastien, et al.
Publicado: (2021)

Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers
por: Jang, Na Young, et al.
Publicado: (2012)

Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)
por: Stangl, Stefan, et al.
Publicado: (2017)

Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2015)

Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma
por: Kumpitsch, Christina, et al.
Publicado: (2020)

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
por: Wiegand, Susanne, et al.
Publicado: (2023)

G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
por: Pottel, Lies, et al.
Publicado: (2015)

Aurora Kinase Inhibition Overcomes Cetuximab Resistance in Squamous Cell Cancer of the Head and Neck
por: Hoellein, Alexander, et al.
Publicado: (2011)

Radiochemotherapy
Publicado: (1998)

DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
por: Tawk, Bouchra, et al.
Publicado: (2023)

Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancer
por: Sauter, Christina, et al.
Publicado: (2022)

Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer
por: Lazzeroni, Marta, et al.
Publicado: (2021)

Association of Genetic Variants in ANGPT/TEK and VEGF/VEGFR with Progression and Survival in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy or Radiochemotherapy
por: Butkiewicz, Dorota, et al.
Publicado: (2020)

Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer
por: Loeffelbein, Denys J, et al.
Publicado: (2014)

The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism
por: Pickhard, Anja, et al.
Publicado: (2014)

Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells
por: Summerer, Isolde, et al.
Publicado: (2015)

An expression analysis of markers of radiation-induced skin fibrosis and angiogenesis in wound healing disorders of the head and neck
por: Koerdt, Steffen, et al.
Publicado: (2015)

Dual-energy CT parameters in correlation to MRI-based apparent diffusion coefficient: evaluation in rectal cancer after radiochemotherapy
por: Sauter, Andreas P, et al.
Publicado: (2020)

Epigenetic Modifications in Head and Neck Cancer
por: Gaździcka, Jadwiga, et al.
Publicado: (2019)

Effektivität einer sequenziellen versus einer simultanen Radiochemotherapie oder alleinigen Radiotherapie bei der adjuvanten Behandlung des Zervixkarzinoms nach Hysterektomie
por: Schiller, Kilian, et al.
Publicado: (2021)

Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
por: Niewald, Marcus, et al.
Publicado: (2011)

Bradykinin Receptor B1 and C-Reactive Protein as Prognostic Factors for Pharyngocutaneous Fistula Development After Laryngectomy
por: Koob, Isabelle, et al.
Publicado: (2019)

Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy
por: Gomez-Millan, J., et al.
Publicado: (2016)

Human cytomegalovirus and Epstein-Barr virus infections increase the risk of death in patients with head and neck cancers receiving radiotherapy or radiochemotherapy
por: Kiprian, Dorota, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gu2o3b572pftsn1gid1eca3nag